African Journal of Biomedical Sciences
Editor-in-Chief: Dr. Abdelmonem Awad Hegazy | ISSN: 3136-8026 | Frequency: Biannual | Publication Format: Open Access | Language: English | Indexing/Listing :

Current Issue of African Journal of Biomedical Sciences

Volume 2, Issue 1, January 2026
Research Paper

Performance evaluation of point-of-care CD4 cell counting devices compared with conventional laboratory methods

| Open Access

Taylor Fischer1*

Afj.Bio.Med.Sci. 2(1) (2026) 1-8, DOI: https://doi.org/10.62587/AFJBMS.2.1.2026.1-8
Received: 11/09/2025|Accepted: 21/12/2025|Published: 25/01/2026

Abstract

Background: CD4 cell counting is important for determining immune status and determining care for people living with HIV and in regions where laboratory CD4 cell testing is not easily available. While point-of-care devices can enhance access, acceptability of results needs to be ensured with the reference flow cytometry. The aim of this study was to assess the level of agreement and clinical classification performance of two point of care CD4 counting methods to the flow cytometry platform. Methods: In 240 patients, comparison between paired CD4 counts obtained from two point-of-care devices and reference flow cytometry using Pearson correlation, Lin’s concordance correlation coefficient, Bland-Altman analysis and diagnostic performance at CD4 thresholds of 200 and 350 cells/μL in 240 patients. Results: Strong Pearson correlation between both devices and reference flow cytometry was demonstrated with Pearson r values of 0.974 for Device A and 0.992 for Device B and concordance of 0.960 and 0.989 respectively. The mean bias values were –34.2 cells/μL for Device A and –13.5 cells/μL for Device B. The sensitivity and specificity were 79% for Device A and 89% for Device B, and 94% for Device A and 97% for Device B, respectively, when counting below 200 cells/μL. The respectives overall misclassifications of Device A and Device B were 8.3% and 4.6%. Conclusion: Both point-of-care devices exhibited good degree of agreement with reference flow cytometry with Device B having a smaller bias and lower misclassification. Point-of-care testing can contribute to decentralisation of CD4 testing, but borderline results can be verified using reference testing.


Keywords: CD4 count, Point-of-care testing, Flow cytometry, Method comparison, Bland-Altman, Concordance, HIV, Limits of agreement

 Full text  Download  XML